A new study has found that laser trabeculoplasty and prostaglandin analogs are cost-effective options in managing glaucoma, but trabeculoplasty may be better in patients at risk for poor adherence. Medscape Medical News
Day: February 13, 2012
New Glaucoma Drug Approved
(MedPage Today) — The FDA has approved an ophthalmic solution of tafluprost (Zioptan), a prostaglandin analog, for patients with open-angle glaucoma, its manufacturer said Monday.
Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt’s macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human e…
Merck’s ZIOPTAN for reducing elevated IOP receives FDA approval
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has approved ZIOPTANTM (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution.
Regeneron reports total revenues of $123.0M for fourth quarter 2011
Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.
Comparative Eye Anatomy (ophthalmology)
Comparative Eye Anatomy (ophthalmology)
A video rich examination of the various eyes in the animal kingdom, and what they can teach us about the human eye. The first half of this lecture discuses the progression of ocular complexity from single-cell…